Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 7.45B 1.12B 996M 917M 832M 1.58B 105B 1.62B 10.97B 4.37B 56.02B 4.19B 4.1B 176B P/E 2026 *
16.7x
P/E 2027 * 13.1x
Enterprise Value 5.13B 769M 686M 631M 573M 1.09B 72.03B 1.11B 7.55B 3.01B 38.56B 2.88B 2.82B 121B EV / Sales 2026 *
0.29x
EV / Sales 2027 * 0.29x
Free-Float
51.88%
Yield 2026 *
3.02%
Yield 2027 * 3.52%
1 day-3.71%
1 week-2.04%
Current month-2.04%
1 month+20.74%
3 months+14.26%
6 months+1.56%
Current year+0.93%
1 week 12.95
Extreme 12.95
13.7
1 month 10.95
Extreme 10.95
13.7
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
14.8
3 years 9.41
Extreme 9.41
26.45
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 2023-11-21
President 60 2019-11-24
Director of Finance/CFO 44 2023-11-21
Director TitleAgeSince
Chairman 60 2009-05-31
Chairman 61 2009-05-31
Director/Board Member 44 2016-11-15
Date Insider Type Main position Quantity % Market Cap. Importance
5/12/26 Buy

Founder

1,359,000 0.3397%
5/12/26 Sell

Founder

-2,727,600 0.6818%
5/11/26 Sell

Founder

-8,806,300 2.2012%
Change 5-day change 1-year change 3-year change Capi.($)
-3.71%-2.04%-4.14%-43.17% 1.16B
-0.60%+12.86%-27.73%+10.26% 17.6B
+5.51%+11.38%-7.21%+15.46% 6.77B
+4.32%+7.49%-3.20%+8.49% 6.66B
-1.77%+7.79%-45.72%-38.24% 6.39B
-6.46%-4.31%+6.93%-14.36% 4.91B
-19.24%-0.27%-31.66%-41.48% 4.72B
-4.42%+1.38%+12.30%-16.54% 3.66B
+1.15%+1.27%-17.81%-30.27% 3.15B
+1.03%+6.18%-10.03%-17.19% 3.17B
Average -2.42%+2.12%-12.83%-16.70% 5.82B
Weighted average by Cap. -1.58%+5.43%-17.41%-7.38%

Financials

2026 *2027 *
Net sales 17.48B 2.62B 2.34B 2.15B 1.95B 3.7B 245B 3.79B 25.73B 10.26B 131B 9.83B 9.62B 414B 18.65B 2.79B 2.49B 2.29B 2.08B 3.95B 262B 4.04B 27.45B 10.94B 140B 10.48B 10.26B 441B
Net income 452M 67.77M 60.49M 55.67M 50.52M 95.74M 6.35B 98.12M 666M 265M 3.4B 254M 249M 10.71B 579M 86.8M 77.47M 71.29M 64.7M 123M 8.14B 126M 853M 340M 4.36B 326M 319M 13.72B
Net Debt -2.32B -348M -311M -286M -259M -491M -32.61B -504M -3.42B -1.36B -17.46B -1.31B -1.28B -54.98B -2.02B -303M -271M -249M -226M -428M -28.43B -439M -2.98B -1.19B -15.22B -1.14B -1.11B -47.94B
Projected Income Statement - Annual - Yixintang Pharmaceutical Group Co., Ltd.
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
26-11-08 CN¥12.98 -3.71% 13,057,710
26-11-06 CN¥13.48 0.00% 8,205,300
26-11-05 CN¥13.48 +0.52% 12,696,983
26-11-04 CN¥13.41 -1.32% 11,559,802
26-11-03 CN¥13.59 +0.37% 11,744,791
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Yixintang Pharmaceutical Group Co., Ltd.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
12.98CNY
Average target price
13.61CNY
Spread / Average Target
+4.85%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Yixintang Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002727 Stock